Indication

Prevention of inhalation anthrax

Prevention of inhalation anthrax refers to pre-exposure prophylaxis or post-exposure prophylaxis aimed at impeding the onset of invasive disease following known, suspected, or anticipated aerosol exposure to *Bacillus anthracis* spores. Read more about Prevention of inhalation anthrax

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Prevention of inhalation anthrax therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Prevention of inhalation anthrax preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Prevention of inhalation anthrax.

Prevention of inhalation anthrax refers to pre-exposure prophylaxis or post-exposure prophylaxis aimed at impeding the onset of invasive disease following known, suspected, or anticipated aerosol exposure to *Bacillus anthracis* spores.

Inhalation anthrax primarily compromises the respiratory and reticuloendothelial systems when inhaled endospores are ingested by alveolar macrophages and transported to mediastinal and hilar lymph nodes.

Upon germination, vegetative bacilli release potent exotoxins—lethal toxin and edema toxin—leading to hemorrhagic mediastinitis, necrotizing lymphadenitis, pleural effusions, systemic bacteremia, and septic shock.

Preventive interventions target exposed or high-risk populations during the asymptomatic incubation window before spore germination causes irreversible systemic toxemia and respiratory failure.

Personalize your experience

Follow Prevention of inhalation anthrax and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it